trending Market Intelligence /marketintelligence/en/news-insights/trending/qggn__iajwro8gwk6tqxug2 content esgSubNav
In This List

Zai Lab appoints chief commercial officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zai Lab appoints chief commercial officer

Zai Lab Ltd. appointed William Liang chief commercial officer.

Liang previously served as vice president at AstraZeneca PLC, heading the oncology business unit in China.

Zai Lab is a Shanghai-based biopharmaceutical company focused on medicines for cancer, autoimmune and infectious diseases in China and around the world.